Federal Judge Allows Collective Lawsuit Against Juul Marketing

Jun.30.2022
Federal Judge Allows Collective Lawsuit Against Juul Marketing
A US federal judge allows collective lawsuits against Juul, accusing the company of misleading marketing and demanding compensation for its purchasers.

A federal judge has permitted both adult and underage individuals who have purchased Juul e-cigarettes to file a collective lawsuit, demanding compensation from the company for deceptive marketing practices.

 

On Tuesday, U.S. District Judge William Orrick certified four groups, consisting of adults and minors both nationwide and in California, but rejected arguments made by Juul and its largest shareholder, tobacco giant Altria Group Inc., stating that the potential members of the collective were too diverse to bring a lawsuit for their claims together.

 

These class-action lawsuits do not accuse the product of causing bodily harm, but rather demand a refund of the money spent on purchasing Juul products.

 

The above is part of the multi-district litigation being handled by Orrick, which includes personal injury claims and lawsuits brought by local governments and school districts alleging that Juul fueled an epidemic of youth addiction.

 

Lawyers for plaintiffs Juul and Altria did not immediately respond to requests for comment.

 

The economic loss claims allege that Juul downplayed the addictive nature of its products and, had it not been for deceptive marketing, consumers would not have purchased these products or would have spent less money on them.

 

Juul argues that they should not be classified as a class-action lawsuit because different consumers were exposed to different advertisements, and some individuals became addicted while others did not.

 

However, Orrick believes that these differences are "largely immaterial under the legal theory being asserted.

 

Under pressure from regulators, Juul removed popular flavors such as mango and cucumber from retail stores in 2018 and closed its social media channels on Instagram and Facebook.

 

Earlier this month, the US Food and Drug Administration (FDA) ordered the removal of all Juul e-cigarettes from the market, but this decision was temporarily halted by the federal appeals court.

 

Juul has agreed to pay over $87 million to settle charges related to its marketing of products to minors with four states.

 

Source: Reuters

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Russian consumer group urges Kremlin administration to reject regional vape sales bans
Russian consumer group urges Kremlin administration to reject regional vape sales bans
A Russian consumer organization has urged the Presidential Administration to block proposals that would let regions ban ENDS and e-liquid sales, warning it would create fragmented regulation and turbocharge the illicit market. The group cites WHO statistics and overseas experiences to argue for a more targeted regulatory model.
Feb.06 by 2FIRSTS.ai
Over 160 organizations urge Formula 1 to end all tobacco sponsorships, including nicotine pouches
Over 160 organizations urge Formula 1 to end all tobacco sponsorships, including nicotine pouches
On March 4, 2026, more than 160 public interest organizations worldwide sent a letter to Formula 1 urging it to expand its 2006 prohibition on cigarette sponsorships to include nicotine pouches and other tobacco products. The letter states that Philip Morris International sponsors Ferrari to promote ZYN pouches, while British American Tobacco sponsors McLaren with its Velo brand, with logos displayed on cars and drivers’ race suits and promoted on social media.
Mar.06 by 2FIRSTS.ai
STMA Issues Trial Credit Management Rules for E-Cigarette Manufacturers and Wholesalers
STMA Issues Trial Credit Management Rules for E-Cigarette Manufacturers and Wholesalers
Mar.26 by 2FIRSTS.ai
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Group, Inc. announced the nationwide retail expansion of on! PLUS nicotine pouches, a product manufactured by Helix Innovations LLC, an Altria operating company. The product had already been available through e-commerce and participating retailers in North Carolina, Florida and Texas, began wholesale deliveries on March 16, 2026, and is expected to reach participating retailers nationwide starting March 23, 2026.
Mar.24 by 2FIRSTS.ai
Dalton, Georgia considers new licensing rules and caps for vape shops
Dalton, Georgia considers new licensing rules and caps for vape shops
Dalton, Georgia is weighing a proposal to require city licenses for vape shops, limit how many can operate within city limits, and impose a 1,000-foot buffer for new shops from schools and other community facilities. City officials say the ordinance would not eliminate existing vape shops outright, though some may be impacted if ownership changes or licenses expire.
Feb.05 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11